Chair, Board of Directors

Gordon F. Brunner is a retired Chief Technology Officer and member of the Board of Directors for the Proctor & Gamble Company. Brunner was head of Proctor & Gamble’s global research & development for thirteen years from 1987 to 2000. This organization involved massive R&D investment spanning nineteen global technical centers, forty categories of business, 300 brands, and over 8,500 R&D employees.

Board of Directors

Thomas A. Dattilo is a Director of L3 Harris Corporation, a Fortune 200 company that is a provider of a wide range of highly sophisticated electronic technologies to support the government and commercial customers in more than 100 countries. Dattilo was a Chairman of the Board of its predecessor Harris Corporation.

Board of Directors

Kay Napier was the Chief Executive Officer of Arbonne International and President of Natural Products Group from 2009 to 2018. Arbonne is a 39-year-old midmarket, privately held wellness company focused on transforming lives through pure and safe plant-based products in skin care, nutrition and cosmetics.

Board of Directors

Scientific Advisory Board

Professor and Drs. Mutasim, Gloster, Jr. & Claassen Endowed Chair of Dermatology

University of Cincinnati College of Medicine

Director of Sports Dermatology

Chief of Dermatology, VAMC-Cincinnati

Head of Design

Chief Neuroendocrinologist / Founder

Emeritus Professor of Psychiatry & Neurobehavioral Sciences

University of Cincinnati College of Medicine

Chief Executive Officer

Zachary I. Pelzl founded and managed Sharpe Strategy, an algorithmically driven, private sports trading investment fund founded in 2015. Zachary is also a founder of Mons Capital Group, LLC, a wealth management firm and innovation model. Prior to becoming CEO of RxDino, Zachary served as Chief Operating Officer for RxDino from 2020 to 2023.